New in Nature Mental Health: our SMART-D precision medicine trial tested biomarkers to guide sertraline vs bupropion in MDD (rdcu.be/fsf2V). Biomarker-positive patients had better symptom trajectories than those without biomarkers (71.4% vs. 42.9% response rates). #Depression #PrecisionPsychiatry